Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adrian L Harris

Showing results (81-90 of 464) with videos related to

Pageof 47
Sort By:
BMJ (Clinical Research Ed.)|November 30, 2002
Efficacy, safety, and cost of new anticancer drugs. Pessimistic conclusion was not justifiedHilary Calvert, Duncan I Jodrell, James Cassidy, et al.
Frontiers in Oncology|October 14, 2014
The notch ligand JAGGED1 as a target for anti-tumor therapyDemin Li, Massimo Masiero, Alison H Banham, et al.
Advances in Experimental Medicine and Biology|June 22, 2016
Methods: Using Three-Dimensional Culture (Spheroids) as an In Vitro Model of Tumour HypoxiaRussell Leek, David Robert Grimes, Adrian L Harris, et al.
Cell Cycle (Georgetown, Tex.)|November 6, 2009
Role of ATF4 in regulation of autophagy and resistance to drugs and hypoxiaTomasz Rzymski, Manuela Milani, Dean C Singleton, et al.
NPJ Breast Cancer|March 17, 2023
Matters Arising: PREDICT underestimates survival of patients with HER2-positive early-stage breast cancerAhmed M Alaa, Adrian L Harris, Mihaela van der Schaar
Trends in Cancer|October 2, 2024
Accessing the vasculature in cancer: revising an old hallmarkAdrian L Harris, David J Kerr, Francesco Pezzella, et al.
Current Drug Targets|March 9, 2016
Antiangiogenic Resistance and Cancer Metabolism: Opportunities for Synthetic LethalitySimon Lord, Juan M Funes, Adrian L Harris, et al.
Nature Communications|December 12, 2018
Pan-cancer characterisation of microRNA across cancer hallmarks reveals microRNA-mediated downregulation of tumour suppressorsAndrew Dhawan, Jacob G Scott, Adrian L Harris, et al.
Cancer Research|March 18, 2021
The Landscape of the Heritable Cancer GenomeViola Fanfani, Luca Citi, Adrian L Harris, et al.
Seminars in Cancer Biology|June 23, 2020
Dissecting the heritable risk of breast cancer: From statistical methods to susceptibility genesViola Fanfani, Martina Zatopkova, Adrian L Harris, et al.
Pageof 47

Showing results (81-90 of 464) with videos related to

Sort By:
Pageof 47
BMJ (Clinical Research Ed.)|November 30, 2002
Efficacy, safety, and cost of new anticancer drugs. Pessimistic conclusion was not justifiedHilary Calvert, Duncan I Jodrell, James Cassidy, et al.
Frontiers in Oncology|October 14, 2014
The notch ligand JAGGED1 as a target for anti-tumor therapyDemin Li, Massimo Masiero, Alison H Banham, et al.
Advances in Experimental Medicine and Biology|June 22, 2016
Methods: Using Three-Dimensional Culture (Spheroids) as an In Vitro Model of Tumour HypoxiaRussell Leek, David Robert Grimes, Adrian L Harris, et al.
Cell Cycle (Georgetown, Tex.)|November 6, 2009
Role of ATF4 in regulation of autophagy and resistance to drugs and hypoxiaTomasz Rzymski, Manuela Milani, Dean C Singleton, et al.
NPJ Breast Cancer|March 17, 2023
Matters Arising: PREDICT underestimates survival of patients with HER2-positive early-stage breast cancerAhmed M Alaa, Adrian L Harris, Mihaela van der Schaar
Trends in Cancer|October 2, 2024
Accessing the vasculature in cancer: revising an old hallmarkAdrian L Harris, David J Kerr, Francesco Pezzella, et al.
Current Drug Targets|March 9, 2016
Antiangiogenic Resistance and Cancer Metabolism: Opportunities for Synthetic LethalitySimon Lord, Juan M Funes, Adrian L Harris, et al.
Nature Communications|December 12, 2018
Pan-cancer characterisation of microRNA across cancer hallmarks reveals microRNA-mediated downregulation of tumour suppressorsAndrew Dhawan, Jacob G Scott, Adrian L Harris, et al.
Cancer Research|March 18, 2021
The Landscape of the Heritable Cancer GenomeViola Fanfani, Luca Citi, Adrian L Harris, et al.
Seminars in Cancer Biology|June 23, 2020
Dissecting the heritable risk of breast cancer: From statistical methods to susceptibility genesViola Fanfani, Martina Zatopkova, Adrian L Harris, et al.
Pageof 47